Point72 Europe »

Halozyme Therapeutics shares owned by Point72 Europe

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Point72 Europe from 13F filings

Historical chart of Point72 Europe investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Point72 Europe consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Point72 Europe

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.6k 261 36.96